| Urological Disorders and Treatments | Lifetime | 22 | FR 1 | 99.77 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 28 | FR 1 | 99.78 |
| Urinary and Genital Oncology Studies | Lifetime | 15 | FR 1 | 99.82 |
| Renal cell carcinoma treatment | Lifetime | 66 | FR 5 | 99.51 |
| Multiple and Secondary Primary Cancers | Lifetime | 62 | FR 8 | 99.05 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 149 | FR 7 | 99.46 |
| Infectious Disease Case Reports and Treatments | Lifetime | 13 | FR 1 | 98.43 |
| Colorectal Cancer Screening and Detection | Lifetime | 258 | FR 9 | 98.90 |
| Prostate Cancer Treatment and Research | Lifetime | 312 | FR 11 | 99.05 |
| COVID-19 and healthcare impacts | Lifetime | 261 | FR 6 | 96.27 |
| Urinary Bladder and Prostate Research | Lifetime | 258 | FR 8 | 98.48 |
| Pelvic floor disorders treatments | Lifetime | 297 | FR 11 | 98.28 |
| Urologic and reproductive health conditions | Lifetime | 217 | FR 7 | 98.63 |
| Esophageal Cancer Research and Treatment | Lifetime | 425 | FR 8 | 97.65 |
| Ureteral procedures and complications | Lifetime | 178 | FR 4 | 97.65 |
| Genetic factors in colorectal cancer | Lifetime | 725 | FR 24 | 97.61 |
| Renal and Vascular Pathologies | Lifetime | 560 | FR 21 | 96.83 |
| Renal and related cancers | Lifetime | 732 | FR 23 | 96.79 |
| Diversity and Career in Medicine | Lifetime | 658 | FR 2 | 92.68 |
| Sexual function and dysfunction studies | Lifetime | 717 | FR 16 | 94.03 |
| Social Media in Health Education | Lifetime | 458 | FR 3 | 88.88 |
| Nephrotoxicity and Medicinal Plants | Lifetime | 261 | FR 8 | 85.25 |
| Urological Disorders and Treatments | 2021-2025 | 4 | FR 1 | 99.50 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 13 | FR 2 | 99.69 |
| Urinary and Genital Oncology Studies | 2021-2025 | 11 | FR 2 | 99.64 |
| Renal cell carcinoma treatment | 2021-2025 | 89 | FR 7 | 98.45 |
| Prostate Cancer Diagnosis and Treatment | 2021-2025 | 136 | FR 7 | 98.20 |
| Prostate Cancer Treatment and Research | 2021-2025 | 291 | FR 11 | 97.10 |
| Renal and related cancers | 2021-2025 | 183 | FR 8 | 94.47 |
| Urinary Bladder and Prostate Research | 2021-2025 | 236 | FR 19 | 93.58 |
| Renal and Vascular Pathologies | 2021-2025 | 230 | FR 23 | 90.21 |
| Urologic and reproductive health conditions | 2021-2025 | 190 | FR 3 | 90.18 |
| Esophageal Cancer Research and Treatment | 2021-2025 | 643 | FR 10 | 90.52 |
| Infectious Disease Case Reports and Treatments | 2021-2025 | 14 | FR 1 | 87.36 |
| Genital Health and Disease | 2021-2025 | 235 | FR 4 | 88.28 |
| Ureteral procedures and complications | 2021-2025 | 150 | FR 11 | 88.10 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 844 | FR 22 | 89.80 |
| Testicular diseases and treatments | 2021-2025 | 265 | FR 9 | 80.44 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 453 | FR 25 | 77.87 |
| Sexual function and dysfunction studies | 2021-2025 | 599 | FR 8 | 80.13 |
| Hormonal and reproductive studies | 2021-2025 | 838 | FR 18 | 75.61 |
| Male Reproductive Health Studies | 2021-2025 | 346 | FR 9 | 58.42 |
